477 related articles for article (PubMed ID: 29656183)
21. Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling.
Sun YW; Qiu HC; Ou MC; Chen RL; Liang G
Chin J Nat Med; 2018 Jan; 16(1):29-40. PubMed ID: 29425588
[TBL] [Abstract][Full Text] [Related]
22. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
[TBL] [Abstract][Full Text] [Related]
23. Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway.
Zhang K; Rui X; Yan X
Drug Dev Res; 2014 Nov; 75(7):463-8. PubMed ID: 25195681
[TBL] [Abstract][Full Text] [Related]
24. Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma.
Yang X; Xie J; Liu X; Li Z; Fang K; Zhang L; Han M; Zhang Z; Gong Z; Lin X; Shi X; Gao H; Lu K
Cell Biochem Funct; 2019 Apr; 37(3):128-138. PubMed ID: 30883849
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
[TBL] [Abstract][Full Text] [Related]
26. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP
Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746
[TBL] [Abstract][Full Text] [Related]
28. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
29. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Fujita M; Hasegawa A; Yamamori M; Okamura N
J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
[TBL] [Abstract][Full Text] [Related]
31. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells.
Kim SH; Wang WH; Wang JP; Hsieh CH; Fang K
Biomed Pharmacother; 2018 Mar; 99():997-1008. PubMed ID: 29653488
[TBL] [Abstract][Full Text] [Related]
32. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
Nojima H; Kuboki S; Shinoda K; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Miyazaki M
J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):574-84. PubMed ID: 27451128
[TBL] [Abstract][Full Text] [Related]
33. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
[TBL] [Abstract][Full Text] [Related]
34. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
36. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
Shu Y; Lu Y; Pang X; Zheng W; Huang Y; Li J; Ji J; Zhang C; Shen P
Oncotarget; 2016 Nov; 7(47):76984-76994. PubMed ID: 27769068
[TBL] [Abstract][Full Text] [Related]
38. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro.
Zhu Y; Pan Y; Zhang G; Wu Y; Zhong W; Chu C; Qian Y; Zhu G
Biol Pharm Bull; 2018 Jan; 41(1):36-46. PubMed ID: 29093327
[TBL] [Abstract][Full Text] [Related]
39. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
[TBL] [Abstract][Full Text] [Related]
40. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
